glp-1 class drugs glp 1 drug Upcoming wave of hormone-based therapies set to change field of diabetes, obesity care The Boom: A Drug – GLP-1 medications get at the

In fact, cobalamin deficiency is a common cause of metabolic encephalopathy, one of a number of forms of encephalopathy associated with a primary disease (such as FIP) that causes interference with normal brain function and blood-brain barrier mechanisms

doi: 10.1016/j.dnarep.2015.04.002 188 LinY-LLiY

Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide, characterized by an excessive hepatic fat accumulation in the absence of alcoholic abuse, steatogenic medications or others concomitant liver diseases (2)

This would render oral formulations of DSIP virtually ineffective compared to nasal spray and injections [5]

Toxoplasma gondii infection and clinical characteristics of patients with schizophrenia: a systematic review and meta-analysis